Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 55,206 shares at $2.20 ($121K) on 2023-08-09, disclosed to the SEC on 2023-08-10.
Scheduled sale ($121k) by Chief Development & Regulatory under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.20 | 27,603 | $61K | 50.0% |
| 2 | $2.20 | 27,603 | $61K | 50.0% |
| Total | $2.20 avg | 55,206 | $121K | 100% |
| Filing → |
| PRTK | SELL | 2022-11-01 | $12K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $104K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $188K | — | Filing → |